4HY

[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID

Created:2003-01-24
Last modified:  2011-06-04

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count30
Chiral Atom Count0
Bond Count31
Aromatic Bond Count12
2D diagram of 4HY
Toggle HydrogenToggle Labels

Chemical Component Summary

Name[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID
Systematic Name (OpenEye OEToolkits)2-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]ethanoic acid
FormulaC14 H9 I3 O4
Molecular Weight621.932
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs10.04Ic2cc(Oc1c(I)cc(cc1I)CC(=O)O)ccc2O
SMILESCACTVS3.341OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1
SMILESOpenEye OEToolkits1.5.0c1cc(c(cc1Oc2c(cc(cc2I)CC(=O)O)I)I)O
Canonical SMILESCACTVS3.341 OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1
Canonical SMILESOpenEye OEToolkits1.5.0 c1cc(c(cc1Oc2c(cc(cc2I)CC(=O)O)I)I)O
InChIInChI1.03 InChI=1S/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4,6,18H,5H2,(H,19,20)
InChIKeyInChI1.03 UOWZUVNAGUAEQC-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank IDDB03604 
NameTiratricol
Groups
  • investigational
  • approved
DescriptionTiratricol is an analogue and active metabolite of the thyroid hormone triiodothyronine (T3).[L53383] It was first approved by the EMA on February 12, 2025 for the treatment of peripheral thyrotoxicosis in patients with monocarboxylate transporter 8 (MCT8) deficiency,[A274038] a disorder characterized by chronic tissue thyrotoxicosis and abnormal neuronal development due to the impaired thyroid hormone uptake in the brain.[A274073] Tiratricol is currently being investigated in US clinical trials.
Synonyms
  • Triacana
  • Tiratricolum
  • Tiratricol sodium
  • 3',3,5-Triiodothyroacetic acid
  • BENZENEACETIC ACID, 4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODO-
Brand NamesEmcitate
IndicationTiratricol is indicated for the treatment of peripheral thyrotoxicosis in patients with monocarboxylate transporter 8 (MCT8) deficiency (Allan-Herndon-Dudley Syndrome), from birth.[L53383]
Categories
  • Agents used to treat hypothyroidism
  • Amino Acids
  • Amino Acids, Aromatic
  • Amino Acids, Cyclic
  • Amino Acids, Peptides, and Proteins
ATC-Code
  • H03AA04
  • D11AX08
CAS number51-24-1

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Thyroid hormone receptor betaMTPNSMTENGLTAWDKPKHCPDREHDWKLVGMSEACLHRKSHSERRSTLK...unknownagonist
Thyroid hormone receptor alphaMEQKPSKVECGSDPEENSARSPDGKRKRKNGQCSLKTSMSGYIPSYLDKD...unknownagonist
Dihydroorotate dehydrogenase (quinone), mitochondrialMAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLD...unknowninhibitor
Cytochrome P450 3A4MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...unknowninducer
Hepatic sodium/bile acid cotransporterMEAHNASAPFNFTLPPNFGKRPTDLALSVILVFMLFFIMLSLGCTMEFSK...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL41632
PubChem 5803
ChEMBL CHEMBL41632
CCDC/CSD ITYAEA10